About this Publication
ADSHG submission Oct 2017 to the Health Committee enquiry on Brexit - medicines. This submission explores the implementation risks of a transition to new customs arrangements as Britain leaves the European Union and offers some suggestions for contingency planning around management of possible supply chain bottlenecks for both raw materials and basic generic drugs.